Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein

Reactivation of human cytomegalovirus (HCMV) in transplant recipients can cause life-threatening disease. Consequently, for transplant recipients, killing latently infected cells could have far-reaching clinical benefits. In vivo, myeloid cells and their progenitors are an important site of HCMV lat...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishna, B. A., Spiess, K., Poole, E. L., Lau, B., Voigt, S., Kledal, T. N., Rosenkilde, M. M., Sinclair, J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296658/
https://www.ncbi.nlm.nih.gov/pubmed/28148951
http://dx.doi.org/10.1038/ncomms14321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296658/
https://www.ncbi.nlm.nih.gov/pubmed/28148951
http://dx.doi.org/10.1038/ncomms14321

Ejemplares similares